英文字典中文字典51ZiDian.com

中文字典辞典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

请选择你想看的字典辞典：

单词	字典	翻译
companiforme	查看　companiforme　在百度字典中的解释	百度英翻中〔查看〕
companiforme	查看　companiforme　在Google字典中的解释	Google英翻中〔查看〕
companiforme	查看　companiforme　在Yahoo字典中的解释	Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!

中文字典英文字典工具:

选择颜色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://www.51zidian.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://www.51zidian.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">输入中英文单字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查询字典"></td></tr></table></div>
</form>

英文字典中文字典相关资料:

Neuron23
SOUTH SAN FRANCISCO, Calif – December 3, 2024 – Neuron23® Inc , a clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, today announced the recent initiation of dosing in a Phase 1 clinical trial of NEU-111 in healthy volunteers
Neuron23
Our founders established Neuron23 to take advantage of the expanding field of human genetics and develop targeted therapeutics for diseases that have clearly defined genetic contributions
Neuron23
Neuron23 is developing both CNS-penetrant and peripherally restricted TYK2 inhibitors to address both neurological autoimmune and peripheral autoimmune disorders
Neuron23
SOUTH SAN FRANCISCO, Calif – March 25, 2025 – Neuron23® Inc , a clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, today announced the publication of a manuscript in the Proceedings of the National Academy of Sciences (PNAS), which explores the
Neuron23
Neuron23 was founded in late 2018 with the goal of changing the way drugs were discovered and developed for neurodegenerative and immunological diseases, by leveraging data science to pinpoint and exploit key disease drivers
Neuron23
Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases
Neuron23
Neuron23 expects to begin clinical trials for NEU-723, a best-in-class brain-penetrant LRRK2 inhibitor indicated for the treatment of Parkinson’s disease, by the end of 2022 NEU-723 is a highly potent and selective LRRK2 inhibitor
Neuron23
Neuron23 leverages recent advances in human genetics, combined with their state-of-the-art artificial intelligence (AI)-enabled drug discovery and biomarker platforms, to advance therapeutics for devastating diseases
Neuron23
Neuron23 offers a highly competitive total rewards package including a comprehensive set of benefits, generous paid time off, and stock options Our benefits include: Medical

中文字典-英文字典 2005-2009